Technology | July 30, 2013

New Blood Clot Removal System Successfully Restores Blood Flow

Aspire Thrombectomy Device Aspiration Medical

July 30, 2013 — Nick Cavros, interventional cardiologist with Cardiovascular Institute of the South (CIS) at Lafayette General Medical Center in Lafayette, La., used a new hand-held mechanical aspiration system to remove blood clots in the leg and increase blood flow.

The Aspire aspirator connects to any aspiration catheter and aspirates blood clots in blocked arteries and veins. Aspire systems allow clinicians to instantly start, stop, increase, decrease or pulse aspiration during a variety of procedures.

During the procedure in the cath lab, a small catheter is inserted into the patient's leg and is guided to the blocked vessel. Once a catheter is in the vein or artery, the cardiologist can diagnose the location and extent of the lesion. Treatment options vary depending on the age, size and location of the blood clot. Clinicians may follow blood clot aspiration with stent, bypass or other intervention.

"Most people know that blood clots are lethal in the heart and brain. But, blood clots can be life-threatening in the legs, lung and other organs too," said Cavros. "Our CIS team has experience treating a wide range of blood clots with numerous tools. We focus on the patient's needs and tailor the right therapy to improve care — fast."

Blood clot aspiration is typically performed with basic syringes or electromechanical pumps. Basic syringes require two hands to operate, are volume limited and do not maintain consistent aspiration force. Electromechanical systems can aspirate more volume with increased force, but are expensive, can be difficult to use, require extensive set-up and do not give the clinician tactile feedback during aspiration.

"Speed and accuracy is important to remove blood clots and restore blood flow," continued Cavros. "The Aspire system improves aspiration speed and performance, and it allows us to use a variety of catheters specific to the patient's needs."

For more information:

Related Content

ACCESS PTS Study Demonstrates Efficacy of EKOS Therapy for Post-Thrombotic Syndrome
News | Deep Vein Thrombosis| July 07, 2017
BTG plc recently highlighted the results of the ACCESS PTS trial, presented at the Society for Vascular Medicine 28th...
Sponsored Content | Videos | Venous Therapies| June 27, 2017
This video, provided by Ekos, demonstrates the EkoSonic endovascular System thrombolytic system to treat deep vein th
Technology | Pulmonary Embolism| March 01, 2017
March 1, 2017 — BTG plc announced U.S.
global thrombectomy devices market, Allied Market Research report, 2022
News | Thrombectomy Devices| January 05, 2017
January 5, 2017 — A new report published by Allied Market Research forecasts that the global...
News | Analytics Software| October 31, 2016
In an effort to improve patient care, Children's Hospital of Philadelphia's (CHOP) Information Services team is using...
Neuravi, EmboTrap II stent retriever, thrombectomy device, acute stroke, European launch, CE Mark
News | Thrombectomy Devices| September 28, 2016
Neuravi recently announced Conformité Européenne (CE) Mark approval and launch of the company’s newly available...
Penumbra System, ACE68 Reperfusion Catheter, thrombectomy device, SNIS 2016, acute ischemic stroke patients
Technology | Thrombectomy Devices| July 27, 2016
July 27, 2016 — Penumbra Inc. announced U.S.
Technology | Stents Peripheral| April 27, 2016
Veniti Inc. announced the first successful treatment with the Vici Verto Venous Stent System of a patient suffering...
Boston Scientific, Fetch 2 aspiration catheter, Class 1 recall
News | Thrombectomy Devices| April 20, 2016
April 20, 2016 — Boston Scientific Corp. announced a U.S.
Overlay Init